Multiple sclerosis: a study of CXCL10 and CXCR3 co-localization in the inflamed central nervous system

Agostini, 1998, Involvement of the IP-10 chemokine in sarcoid granulomatous reactions, J. Immunol., 161, 6413, 10.4049/jimmunol.161.11.6413

Agostini, 2000, CXC chemokines IP-10 and mig expression and direct migration of pulmonary CD8+/CXCR3+ T cells in the lungs of patients with HIV infection and T-cell alveolitis, Am. J. Respir. Crit. Care Med., 162, 1466, 10.1164/ajrccm.162.4.2003130

Balashov, 1999, CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1α and IP-10 are expressed in demyelinating brain lesions, Proc. Natl. Acad. Sci. U. S. A., 96, 6873, 10.1073/pnas.96.12.6873

Brück, 1994, Oligodendrocytes in the early course of multiple sclerosis, Ann. Neurol., 35, 65, 10.1002/ana.410350111

Brück, 1995, Monocyte/macrophage differentiation in early multiple sclerosis lesions, Ann. Neurol., 38, 788, 10.1002/ana.410380514

Cole, 1998, Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3, J. Exp. Med., 187, 2009, 10.1084/jem.187.12.2009

de Groot, 2001, The role of chemokines and chemokine receptors in CNS inflammation, Prog. Brain Res., 132, 533, 10.1016/S0079-6123(01)32101-5

Fife, 2001, CXCL10 (IFN-gamma-inducible protein-10) control of encephalitogenic CD4+ T cell accumulation in the central nervous system during experimental autoimmune encephalomyelitis, J. Immunol., 166, 7617, 10.4049/jimmunol.166.12.7617

Flier, 2001, Differential expression of CXCR3 targeting chemokines CXCL10, CXCL9, and CXCL11 in different types of skin inflammation, J. Pathol., 194, 398, 10.1002/1096-9896(200108)194:4<397::AID-PATH899>3.0.CO;2-S

Flügel, 2001, Migratory activity and functional changes of green fluorescent effector cells before and during experimental autoimmune encephalomyelitis, Immunity, 14, 547, 10.1016/S1074-7613(01)00143-1

Franciotta, 2001, Serum and CSF levels of MCP-1 and IP-10 in multiple sclerosis patients with acute and stable disease and undergoing immunomodulatory therapies, J. Neuroimmunol., 115, 192, 10.1016/S0165-5728(01)00261-2

Francis, 1991, Demyelinating optic neuritis: clinical features and differential diagnosis, Br. J. Hosp. Med., 45, 376

Glabinski, 1997, Synchronous synthesis of alpha- and beta-chemokines by cells of diverse lineage in the central nervous system of mice with relapses of chronic experimental autoimmune encephalomyelitis, Am. J. Pathol., 150, 617

Godiska, 1995, Chemokine expression in murine experimental allergic encephalomyelitis, J. Neuroimmunol., 58, 167, 10.1016/0165-5728(95)00008-P

Hickey, 1991, T-lymphocyte entry into the central nervous system, J. Neurosci. Res., 28, 254, 10.1002/jnr.490280213

Huang, 2000, Chemokines and chemokine receptors in inflammation of the nervous system: manifold roles and exquisite regulation, Immunol. Rev., 177, 52, 10.1034/j.1600-065X.2000.17709.x

Kieseier, 2002, Chemokines and chemokine receptors in inflammatory demyelinating neuropathies—a central role for IP-10, Brain, 125, 823, 10.1093/brain/awf070

Liu, 2001, Expression of Mig (monokine induced by interferon-gamma) is important in T lymphocyte recruitment and host defense following viral infection of the central nervous system, J. Immunol., 166, 1790, 10.4049/jimmunol.166.3.1790

Liu, 2001, Neutralization of the chemokine cxcl10 reduces inflammatory cell invasion and demyelination and improves neurological function in a viral model of multiple sclerosis, J. Immunol., 167, 4091, 10.4049/jimmunol.167.7.4091

Loetscher, 1996, Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes, J. Exp. Med., 184, 963, 10.1084/jem.184.3.963

Lucchinetti, 2000, Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination, Ann. Neurol., 47, 707, 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q

Luster, 1998, Chemokines—chemotactic cytokines that mediate inflammation, N. Engl. J. Med., 338, 436, 10.1056/NEJM199802123380706

McDonald, 2001, Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis, Ann. Neurol., 50, 121, 10.1002/ana.1032

Misu, 2001, Chemokine receptor expression on T cells in blood and cerebrospinal fluid at relapse and remission of multiple sclerosis: imbalance of Th1/Th2-associated chemokine signaling, J. Neuroimmunol., 114, 207, 10.1016/S0165-5728(00)00456-2

Murphy, 2000, International union of pharmacology: XXII. Nomenclature for chemokine receptors, Pharmacol. Rev., 52, 145

Noseworthy, 1999, Progress in determining the causes and treatment of multiple sclerosis, Nature, 399, A40, 10.1038/399a040

Paty, 1988, MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT, Neurology, 38, 180, 10.1212/WNL.38.2.180

Prat, 2000, Interferon-γ-inducible protein-10 is increased in the cerebrospinal fluid of patients with multiple sclerosis, Mult. Scler., 5, 83

Qin, 1998, The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions, J. Clin. Invest., 101, 746, 10.1172/JCI1422

Rabin, 1999, Chemokine receptor responses on T cells are achieved through regulation of both receptor expression and signaling, J. Immunol., 162, 3840, 10.4049/jimmunol.162.7.3840

Ransohoff, 2000, Chemokine receptor antagonism as a new therapy for multiple sclerosis, Expert Opin. Investig. Drugs, 9, 1079, 10.1517/13543784.9.5.1079

Ransohoff, 1993, Astrocyte expression of mRNA encoding cytokines IP-10 and JE/MCP-1 in experimental autoimmune encephalomyelitis, FASEB J., 7, 592, 10.1096/fasebj.7.6.8472896

Romagnani, 2001, Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity, J. Clin. Invest., 107, 53, 10.1172/JCI9775

Sellebjerg, 1996, Qualitative assessment of intrathecal IgG synthesis by isoelectric focusing and immunodetection: interlaboratory reproducibility and interobserver agreement, Scand. J. Clin. Lab. Invest., 56, 135, 10.3109/00365519609088600

Simpson, 2000, Expression of the interferon-γ-inducible chemokines IP-10 and Mig and their receptor, CXCR3, in multiple sclerosis lesions, Neuropathol. Appl. Neurobiol., 26, 133, 10.1046/j.1365-2990.2000.026002133.x

Sørensen, 1998, Etiology and pathogenesis of multiple sclerosis, Semin. Neurol., 18, 287, 10.1055/s-2008-1040879

Sørensen, 1999, Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients, J. Clin. Invest., 103, 807, 10.1172/JCI5150

Sørensen, 2001, Chemokines, CXCL10 and CCL2: differential involvement in intrathecal inflammation in multiple sclerosis, Eur. J. Neurol., 8, 665, 10.1046/j.1468-1331.2001.00327.x

Tani, 1996, In situ hybridization analysis of glial fibrillary acidic protein mRNA reveals evidence of biphasic astrocyte activation during acute experimental autoimmune encephalomyelitis, Am. J. Pathol., 148, 889

Trebst, 2001, Investigating chemokines and chemokine receptors in patients with multiple sclerosis: opportunities and challenges, Arch. Neurol., 58, 1975, 10.1001/archneur.58.12.1975

Trebst, 2001, CCR1+/CCR5+ mononuclear phagocytes accumulate in the central nervous system of patients with multiple sclerosis, Am. J. Pathol., 159, 1701, 10.1016/S0002-9440(10)63017-9

Wekerle, 1991, Interaction of T lymphocytes with cerebral endothelial cells in vitro, Brain Pathol., 1, 107, 10.1111/j.1750-3639.1991.tb00647.x

Zlotnik, 2000, Chemokines: a new classification system and their role in immunity, Immunity, 12, 121, 10.1016/S1074-7613(00)80165-X